Crizotinib and Lumefantrine: Interaction Details
- Crizotinib
- Xalkori
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Crizotinib and Lumefantrine interaction:
Lumefantrine
We don't have a separate drug information page for Lumefantrine. The FDA's drug directory lists it as part of Coartem (artemether and lumefantrine). Read the Artemether and Lumefantrine drug information page → Have a question about Lumefantrine? Ask a pharmacist, free →
What Happens When You Take Crizotinib With Lumefantrine
What can happen when they are taken together (rated Major)
Increased artemether/lumefantrine exposure and an increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Artemether/lumefantrine should not be given together with QT-prolonging agents such as crizotinib,1 because their effects on QT interval prolongation may be . Crizotinib is a , so giving it with artemether/lumefantrine may also raise exposure to artemether/lumefantrine.2
When the combination cannot be avoided, periodic and electrolyte monitoring should be considered. Crizotinib may be withheld, dose-reduced, or permanently discontinued if QT/ prolongation occurs, depending on clinical need.1 Caution also applies when a QT-prolonging drug is started after artemether/lumefantrine treatment has finished, since lumefantrine has a long (3 to 6 days).2
The Crizotinib and Lumefantrine Interaction, Explained
Both of these medicines can affect your heart's rhythm. Crizotinib (Xalkori, a cancer medicine) and lumefantrine (taken with artemether to treat malaria) can each lengthen the , a measure of how your heart recharges between beats. Together, the effect could add up. Crizotinib may also slow the breakdown of lumefantrine, so more of it could stay in your body. Lumefantrine also lingers for several days after you finish.
This is based on how the drugs work rather than on reports of harm, but it is taken seriously. Please tell your pharmacist or doctor about both medicines. Your care team can decide on the safest plan and may check your heart tracing () and blood salts.
plus possible increased lumefantrine exposure. Crizotinib is a (and ) and itself prolongs . Lumefantrine (with artemether) is a CYP3A4 substrate and also prolongs QTc. Neither is a in a way that reverses the direction, so is expected to raise exposure. Evidence is theoretical, onset unspecified, severity rated major.
- Avoid when possible.
- If necessary, consider periodic and electrolyte monitoring (K, Mg).
- Withhold, reduce, or permanently discontinue crizotinib for QT/QTc prolongation as clinically needed.
- Lumefantrine is 3 to 6 days, so use caution with QT-prolonging drugs after completing therapy.
See the 2 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Crizotinib and Lumefantrine Interact
The likely mechanism
of -mediated of artemether/lumefantrine;
How to Manage the Crizotinib and Lumefantrine Interaction
Your care team will usually try to avoid using these two together. If both are truly needed, they can manage the risk with careful monitoring.
- Keep taking both medicines as prescribed unless your care team tells you otherwise.
- Your team may do periodic ECGs and blood tests for electrolytes such as potassium and magnesium.
- Crizotinib may need to be paused, reduced, or stopped if your heart tracing shows QT changes, and your team will decide this.
- Lumefantrine stays in the body for days, so tell any prescriber about it even after your malaria course ends.
- Report fainting, dizziness, or a racing or irregular heartbeat promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Crizotinib or Lumefantrine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Crizotinib and Lumefantrine: Common Questions
How serious is the Crizotinib and Lumefantrine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Crizotinib and Lumefantrine interaction managed?
Your care team will usually try to avoid using these two together. If both are truly needed, they can manage the risk with careful monitoring. Keep taking both medicines as prescribed unless your care team tells you otherwise. Your team may do periodic ECGs and blood tests for electrolytes such as potassium and magnesium. Crizotinib may need to be paused, reduced, or stopped if your heart tracing… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Crizotinib and Lumefantrine Interaction
Ask in your own words about taking Crizotinib and Lumefantrine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (2)
- Product Information: XALKORI(R) oral pellets, oral capsules, crizotinib oral pellets, oral capsules. Pfizer Labs (per FDA), New York, NY, 2023. DailyMed
- Product Information: COARTEM® oral tablets, artemether lumefantrine oral tablets. Novartis Pharmaceuticals Corporation (per DailyMed), East Hanover, NJ, 2025. DailyMed
Other Serious Interactions of Crizotinib and Lumefantrine
Also serious with Crizotinib
- Ketoconazole TopicalContraindicated
- CobicistatContraindicated
- Cobicistat / Darunavir EthanolateContraindicated
- AtazanavirContraindicated
Also serious with Lumefantrine
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Crizotinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- + 154 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.